AILIS Breast Cancer Prediction Technology
Krak├│w · Founded 2016
About AILIS Breast Cancer Prediction Technology
AILIS is an innovative breast cancer prediction technology which uses Parametric Dynamic Imagining, Artificial Intelligence and telemedicine to detect cancer and predicts the possibility of cancerous changes’something that traditional screening is unable to provide. AILIS technology allows for monitoring the condition of dense breasts in completely comfortable conditions: no contact, compression, or harmful radiation. It’s a revolution that guarantees comfort, safety, and respect to all women, regardless of their religion or culture. Approximately 43% of women all over the world have densely-built breasts. This means that nearly half of the female population has limited access to an efficient method allowing for early cancer detection. AILIS is the answer to this problem, as it responds immediately where mammography needs years.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Funding stage: Seed
- Last round: Grant (Dec 2021)
- Website: https://ailiscare.com/en/
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ailis-breast-cancer-prediction-technology-145811 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.